![](/img/cover-not-exists.png)
Conformational Analysis and Receptor Docking of N -[(1 S ,2 S )-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (Taranabant, MK-0364), a Novel, Acyclic Cannabinoid-1 Receptor Inverse Agonist
Lin, Linus S., Ha, Sookhee, Ball, Richard G., Tsou, Nancy N., Castonguay, Laurie A., Doss, George A., Fong, Tung M., Shen, Chun-Pyn, Xiao, Jing Chen, Goulet, Mark T., Hagmann, William K.Volume:
51
Language:
english
Journal:
Journal of Medicinal Chemistry
DOI:
10.1021/jm7014974
Date:
April, 2008
File:
PDF, 272 KB
english, 2008